Abstract
Summary
The hemodynamic and renal vascular effects of SQ 14,225, a new angiotensin-converting enzyme inhibitor, were studied in mongrel dogs under pentobarbital anesthesia. A dose-related inhibition of the pressor and renal vasoconstrictor effects of AI, but not of AII, were seen after SQ 14,225. After administration of SQ 14,225 (310 μg/kg iv) a moderate decrease in arterial pressure and increase in renal blood flow were observed. It is proposed that the hypotension and renal vasodilation seen after SQ 14,225 could be due to loss of endogenous AII; however, an enhancement of endogenously produced bradykinin cannot be excluded.
Get full access to this article
View all access options for this article.